Click here to invite colleagues to join the Forum for FREE Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact Expert Views Hot Topics from the 4th Meeting of the PCSK9 Forum Editorial Board Amsterdam, The Netherlands The ‘Legacy’ effect Professor Chris Packard discusses this effect observed in WOSCOPS and other statin trials, and the possible contributing mechanisms. Listen here » PCSK9 inhibitors: Balancing value and cost A critical appraisal of the Institute for Clinical and Economic Review (ICER) report by Ciaran Kohli-Lynch, working with Professor Andrew Briggs, University of Glasgow, UK. Listen here » Understanding lipoprotein-associated PCSK9: Physiological implications? Professor Sergio Fazio, The Knight Cardiovascular Institute of OHSU, Portland, USA overviews the latest data: Does lipoprotein-bound PCSK9 more accurately reflect PCSK9 activity? Listen here » New and updated edition of our popular therapeutic guide A second edition of the free introductory guide: PCSK9 Inhibition - New Therapies in Cardiovascular Risk Reduction is now available on the Forum’s website. This very popular book has been updated with the latest information discussing the biology and therapeutic potential of PCSK9 inhibition. As you know, this downloadable e-book is freely available to all registered members of the Forum. Read online » Download now » Forward to colleagues » Questions & Answers Inhibition of PCSK9 offers the real possibility of improved management of high-risk patients. Read the full answer and other questions on the PCSK9 Forum » Like us on Facebook For the latest updates, PCSK9 news and analysis. Follow us on Twitter Hot topics, news and conference reports. YouTube Channel For videos, interviews and webcasts from leading experts. Educational Partners and Supporters Copyright PCSK9 Forum 2016. Please click here to unsubscribe from future mailings.